kentucky semaglutide gastric intestinal obstruction lawsuit Pharmaceutical giant Novo Nordisk is facing mounting legal pressure as more than 1,800 lawsuits have been filed in the United States over alleged severe side effects linked to Ozempic and similar weight-loss Ozempic lawsuits allege severe side
Description
Westgate CSJ, Israelsen IME, Jensen RH, Eftekhari S (2021) Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension
These mechanisms lead to significant caloric reduction and subsequent weight loss
It contains the active drug semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps to decrease appetite and increase feelings of fullness, thereby aiding in weight loss
This is particularly important as we need more effective treatments for moderate-to-severe disease
Editor, www.cmeindia.in
